Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: A systemic review and meta‐analysis

BACKGROUND: To evaluate the immune checkpoint inhibitors (CPI) for the treatment of patients with advanced cutaneous squamous cell carcinoma (CSCC). MATERIALS AND METHODS: A meta‐analysis was conducted, and the efficacy and safety of CPI were assessed. RESULTS: A total of 13 studies with 980 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haoran, Zhong, Ai, Chen, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838749/
https://www.ncbi.nlm.nih.gov/pubmed/36329570
http://dx.doi.org/10.1111/srt.13229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838749/
https://www.ncbi.nlm.nih.gov/pubmed/36329570
http://dx.doi.org/10.1111/srt.13229

Ejemplares similares